ESS vs TERN · P/E 31, rev $1.89B vs $6.12B cap
Essex Property Trust Inc (ESS) versus Terns Pharmaceuticals Inc (TERN) — a side-by-side from cached financials, not a winner call.
Essex Property Trust Inc (ESS) is a reit - residential company listed on NYSE.
Terns Pharmaceuticals Inc (TERN) is a biotechnology company listed on NASDAQ.
Latest reported ESS revenue for 2025-12-31 was $1.89B. Net income was $702.8M. Revenue was up 6.4% from 2024-12-31 to 2025-12-31. ESS currently screens at market cap $18.91B and trailing P/E 30.9.
Latest reported TERN revenue for 2022-12-31 was $0. Net income was -$60.3M. TERN currently screens at market cap $6.12B.
ESS currently screens at market cap $18.91B and trailing P/E 30.9. TERN currently screens at market cap $6.12B.
Not investment advice. Open the ESS and TERN stock pages for the full models.
Not investment advice.